News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Morisset Valerie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2023 |
4
| Morisset Valerie (EVP, R&D and CSO) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Exercised 255,219 options to buy
@ $0.002, valued at
$510.4
Exercised 61,191 options to buy
@ $0.0002, valued at
$12.2 |
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Morisset Valerie (EVP, R&D and CSO) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 170,000 options to buy
@ $8.21, valued at
$1.4M
|
|
| 08/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|